Literature DB >> 9175006

The effects of chronic hypoxia on renal function in the rat.

M Neylon1, J M Marshall, E J Johns.   

Abstract

1. Studies were performed on rats that had been made chronically hypoxic (CH rats) in a normoxic chamber at 12% O2 for 3-5 weeks. Under Saffan anaesthesia, respiratory and cardiovascular variables, renal haemodynamics and renal function were recorded while the rats spontaneously breathed 12% O2 followed by a switch to air breathing for 20 min. Plasma renin activity was assessed by radioimmunoassay of angiotensin I. Plasma atrial natiruetic peptide (ANP) was indirectly assessed by measurement of cyclic GMP in urine. 2. When breathing 12% O2, CH rats showed hyperventilation and raised haematocrit (52%) relative to normoxic (N) rats. But arterial pressure (ABP), renal blood flow (RBF), renal vascular conductance (RVC), mean right atrial pressure (mRAtP), urine flow, glomerular filtration rate (GFR) and absolute sodium excretion (UNaV) were comparable to those recorded in N rats breathing air. Urinary cGMP was 40% greater than in N rats, but plasma renin activity was not significantly greater in CH than in N rats. 3. Air breathing in CH rats induced hypoventilation, a 12% increase in ABP, no change in mRAtP, RBF or GFR, but increases of 75 and 100% in urine flow and UNaV, respectively. Neither urinary cGMP nor plasma renin activity changed. Such increases in urine flow and UNaV were absent when renal perfusion pressure (RPP) was prevented from rising during air breathing by using an occluder on the dorsal aorta. 4. We propose that by 3-5 weeks of chronic hypoxia renal function was normalized, principally because arterial O2 content was normalized by the increase in haematocrit and because ABP and renal haemodynamics were normalized: acute hypoxia in N rats produces a fall in ABP. We suggest that plasma ANP was raised by the actions of hypoxia or erythropoietin on the atrium, rather than by atrial distension, but suggest that ANP had little direct influence on renal function and tended to limit the influence of the renin-angiotensin system. We further propose that the diuresis and natriuresis seen during air breathing were mediated by the increase in RPP; neither plasma ANP nor renin activity change in the immediate short term.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175006      PMCID: PMC1159516          DOI: 10.1111/j.1469-7793.1997.243bo.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  22 in total

1.  INTER-RELATIONSHIPS BETWEEN RENAL AND CARDIAC FUNCTION AND RESPIRATORY GAS EXCHANGE IN OBSTRUCTIVE AIRWAYS DISEASE.

Authors:  G M ABER; T J BAYLEY; J M BISHOP
Journal:  Clin Sci       Date:  1963-10       Impact factor: 6.124

2.  Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease.

Authors:  M O Farber; S S Kiblawi; R A Strawbridge; G L Robertson; M H Weinberger; F Manfredi
Journal:  J Lab Clin Med       Date:  1977-08

3.  Effect of normoxemic and hypoxemic exercise on renin and aldosterone.

Authors:  J W Shigeoka; G L Colice; G Ramirez
Journal:  J Appl Physiol (1985)       Date:  1985-07

Review 4.  Mediation of Ventilatory Adaptations.

Authors:  J A Dempsey; H V Forster
Journal:  Physiol Rev       Date:  1982-01       Impact factor: 37.312

5.  The role of the renin-angiotensin system in the renal response to moderate hypoxia in the rat.

Authors:  M Neylon; J Marshall; E J Johns
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

6.  Angiotensin converting enzyme response to hypoxia in man: its role in altitude acclimatization.

Authors:  J S Milledge; D M Catley
Journal:  Clin Sci (Lond)       Date:  1984-10       Impact factor: 6.124

7.  Renin-aldosterone and angiotensin-converting enzyme during prolonged altitude exposure.

Authors:  J S Milledge; D M Catley; M P Ward; E S Williams; C R Clarke
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-09

8.  Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

Authors:  S Adnot; P Andrivet; P E Chabrier; J Piquet; P Plas; P Braquet; F Roudot-Thoraval; C Brun-Buisson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats.

Authors:  R J Winter; L Meleagros; S Pervez; H Jamal; T Krausz; J M Polak; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1989-01       Impact factor: 6.124

10.  Hypoxia-induced release of atrial natriuretic factor (ANF) from the isolated rat and rabbit heart.

Authors:  A J Baertschi; C Hausmaninger; R S Walsh; R M Mentzer; D A Wyatt; R A Pence
Journal:  Biochem Biophys Res Commun       Date:  1986-10-15       Impact factor: 3.575

View more
  3 in total

1.  Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report.

Authors:  Petter Bjornstad; Julie A Lovshin; Yuliya Lytvyn; Leif E Lovblom; Daniel Scarr; Geneviève Boulet; Mohammed A Farooqi; Andrej Orszag; Johnny-Wei Bai; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney
Journal:  J Diabetes Complications       Date:  2019-05-17       Impact factor: 2.852

2.  Impact of continuous positive airway pressure (CPAP) on the respiratory capacity of chronic kidney disease patients under hemodialysis treatment.

Authors:  Vivian Bertoni Xavier; Renata Spósito Roxo; Luiz Antônio Miorin; Vera Lúcia Dos Santos Alves; Yvoty Alves Dos Santos Sens
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

3.  Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.

Authors:  Lyubov Chaykovska; Fabian Heunisch; Gina von Einem; Carl-Friedrich Hocher; Oleg Tsuprykov; Mira Pavkovic; Peter Sandner; Axel Kretschmer; Chang Chu; Saban Elitok; Johannes-Peter Stasch; Berthold Hocher
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.